Abdlatif Alghaiheb

Prof. Abdlatif Alghaiheb


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2011 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
AAAbdlatif Alghaiheb
Abdlatif Alghaiheb
Prescribing errors phenomena are very common within health care practice. These errors could result in adverse events and harm to patients. Pharmacist has an identified role in minimizing and preventing such errors. To detect the incidence of prescribing errors for hospitalized patient, to evaluate the clinical impact of pharmacist intervention on the detection of these errors, and to propose a program to overcome this problem in a teaching hospital. For one month period starting November until December 2009, the inpatient medication charts and orders were identified and rectified by ward and practicing pharmacists within inpatient pharmacy services in a teaching hospital at King Khalid University Hospital (KKUH) at King Saud University, Riyadh, Kingdom of Saudi Arabia on routine daily activities. Data were collected and evaluated. The causes of this problem were identified. Approximately 113 (7.1%) prescribing errors were detected during the study period out of 1580 medication orders. Wrong strength and wrong administration frequency of the prescribed drug were the most errors encountered in the study, which were 35%, and 23%, respectively. Other errors such as wrong patient, wrong drug, and wrong dose were also encountered. Lack of knowledge of prescribing skill was the main cause of such errors. Prescribing errors in teaching hospital within inpatient pharmacy services were noticed. The applied method in this project might be implemented as part of pharmacy quality assurance program for ongoing detection and monitoring of such errors. Technology in prescribing process will support the practitioner to reduce the incidence of these errors. Forcing ongoing professional communication and education within the medical team about prescribing errors now appear warranted.

1 January 2011 in Saudi Medical Journal
Verified
Journal Article
Closed access
AAAbdlatif Alghaiheb
Abdlatif Alghaiheb
OBJECTIVES: To investigate the intravenous (IV) medication wastage within the inpatient pharmacy services at a teaching hospital, and to highlight the main causes for such waste and propose a policy to minimize wastage based on the study findings. METHODS: For a one month period starting from September until October 2009, the returned and unused IV medications to the inpatient pharmacy in a teaching hospital at King Khalid University Hospital of King Saud University, Riyadh, Kingdom of Saudi Arabia were observed daily. Data were collected and evaluated. The causes of this problem were analyzed. RESULTS: Approximately 265 items of IV medication were collected during the study period. Antibiotics preparations (77%) were the most unused and wasted. Medication discontinuation (60%) was the main cause for such wastage. CONCLUSIONS: The problem of IV medication wastage was noticed and investigated. The main causes of such problems were specified, and a program to minimize the wastage was proposed. Further study with more data for longer time is required, followed by an evaluation of the impact of applying the proposed program.

6 May 2015 in Tropical Journal of Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
MAMa Alotaibi
Ma Alotaibi
AFAk Fataftah
Ak Fataftah
KAK Alkhanbashi
K Alkhanbashi
AAAbdlatif Alghaiheb
Abdlatif Alghaiheb
FAFa Alanazi
Fa Alanazi
MAMohammed Alsultan
Mohammed Alsultan
Dose Determination of Activated Charcoal in Management of Amitriptyline-Induced Poisoning by Reversed-Phase High-Performance Liquid Chromatography

6 December 2019 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
PDF file
YAYazed AlRuthia
Yazed AlRuthia
NANasser Yahya Al-Washali
Nasser Yahya Al-Washali
RARaneem Aljuhani
Raneem Aljuhani
ISIbrahim Sales
Ibrahim Sales
BBBander Balkhi
Bander Balkhi
MAMonira Alwhaibi
Monira Alwhaibi
Background: The need for graduate education in Pharmaceutical Outcomes and Policy Research (POPR) is becoming increasingly apparent worldwide. However, the number of professionals in this field is inadequate in the Middle East. Therefore, this study aimed at gaining insight into the perceived value of a potential Doctor of Philosophy (Ph.D.) program in POPR among different stakeholders in Saudi Arabia. Methods: Following the development of a Ph.D. program structure in POPR, a questionnaire was created to explore the perception of its value among decision-makers in different healthcare and governmental institutions. An email with detailed information on the proposed program was sent to 131 identified individuals along with an online link to the questionnaire. Results: Responses were provided by 107 (81.67%) individuals. The majority of respondents (53.3%) represented large organizations with more than 500 workers; hospitals and academia were the most represented types of institutions. More than 85% of the participants strongly agreed that the program will meet the needs of the healthcare market in Saudi Arabia and that there will be a demand for graduates of the program over the next 5–10 years. However, only 28.04% of the participants declared that they would definitely recommend the program to their colleagues and employees, and 49.53% would consider employing its graduates. Conclusions: The obtained results indicate a significant interest among different stakeholders in introducing a Ph.D. program in POPR in Saudi Arabia.

15 October 2026 in Brain Sciences
Verified
Journal Article
Open access
PDF file
WAWaad Hasan Alkathiri
Waad Hasan Alkathiri
SASaeed Alqahtani
Saeed Alqahtani
AAAbdlatif Alghaiheb
Abdlatif Alghaiheb
BABandar Aljafen
Bandar Aljafen
BBBander Balkhi
Bander Balkhi
Background: This study aimed to estimate treatment retention rates for levetiracetam monotherapy in patients with epilepsy and to characterize treatment failure in this population. Methods: A retrospective cohort study included 769 adult patients with epilepsy between 2015 and 2024 at a tertiary hospital in Saudi Arabia who initiated levetiracetam monotherapy. The date of levetiracetam initiation was designated as the index date, and patients were followed from that point until treatment failure or censoring. Treatment failure was defined as either discontinuation of levetiracetam because of adverse events or the addition of another antiseizure medication due to insufficient seizure control. Kaplan–Meier survival analysis was used to estimate the probability of remaining on levetiracetam monotherapy over the follow-up period. Differences in patient characteristics were assessed between the treatment-failure and success groups using Student’s t-test for continuous variables and either the chi-square test or Fisher’s exact test for categorical variables. Results: Of the 769 patients who initiated levetiracetam monotherapy, 143 (18.55%) experienced treatment failure during the 10-year follow-up period. The overall mean time to levetiracetam treatment failure was 93.58 months. The 25th percentile time to treatment failure was 95 months (95% CI: 60.167–103.133). The median time to treatment failure was not reached. Females comprised 50.3% of the cohort, with no significant difference in sex distribution between groups (p = 0.136). Patients in the treatment-failure group were younger (39.85 ± 16.88 vs. 45.76 ± 19.48, p = 0.0003), had higher estimated Creatinine clearance (CrCl) (132.19 ± 57.83 vs. 118.50 ± 61.15, p = 0.0150), and had predominantly generalized seizure onset (40.56% vs. 33.71%, p = 0.0182) compared with the treatment-success group. Conclusions: Levetiracetam monotherapy demonstrated sustained long-term treatment retention when used as first-line therapy in adults with epilepsy.

1 May 2026 in Medicine
Verified
Journal Article
Open access
SASultan Hassan Alshehri
Sultan Hassan Alshehri
AAAbdlatif Alghaiheb
Abdlatif Alghaiheb
RERahaf Wissam Elserraj
Rahaf Wissam Elserraj
HAHanouf Omar Aldeeb
Hanouf Omar Aldeeb
WAWaad Hassan Alkathiri
Waad Hassan Alkathiri
MAMahmood Basil A. Al-Rawi
Mahmood Basil A. Al-Rawi
Pharmaceutical Care (PC) has emerged as a vital component of the healthcare system, involving the provision of medication therapy to achieve specific outcomes that enhance a patient’s quality of life. Therefore, this study aims to evaluate PharmD interns’ self-reported attitudes, perceptions of the skills required to provide PC using multiple domains (technical, psychosocial, communication, and administrative aspects) and perceived barriers to implementing PC, and recommendations. A cross-sectional study was conducted between May and December 2023, utilizing pretested questionnaires with PharmD interns at Saudi universities in Riyadh, Saudi Arabia. The questionnaire included sociodemographic information, attitudes (13 items), perceptions (24 items), importance (19 items), barriers (17 items) toward PC, and recommendations (4 items). To find out the association between variables chi-square, Analysis of Variance, and Spearman correlation were used to examine differences in perceptions and correlations between attitude and perception scores, with a P value < .05 considered statistically significant. A total of 216 PharmD interns participated, with 59.7% being male, 94.9% Saudi nationals, and a mean age of 24.08 ± 0.98 years. The majority (72.7%) were 24 years old. Participants were from public (57.9%) and private (42.1%) universities in Riyadh. The mean attitude score towards PC was 51.25 ± 9.38, and the mean perception score was 106.67 ± 16.01. Attitude scores were significantly associated with gender and university type ( P < .001), while perception scores showed significant associations with gender, age, and university type ( P < .01). The results of the Spearman correlation analysis indicated a moderate, statistically significant positive correlation between mean attitude and mean perception scores ( R = 0.345, P < .01). Most interns agreed that pharmacists should prevent and solve medication-related problems (86.6%) and provide PC (85.7%). However, 43.5% believed that PC is not worth the additional workload. The most frequently reported barriers were lack of financial compensation (65.8%), inadequate staffing (62.5%), limited private counseling areas (60.7%). Most of the PharmD interns have a positive attitude towards PC but face structural and educational barriers to PC implementation. Future research should focus on overcoming these barriers and promoting Interprofessional healthcare courses to enhance patient outcomes.